Diagnostic Hybrids

home > about us > news

December 18, 2006 Diagnostic HYBRIDS Enters into Licensing Agreement for Rapid Detection of hMPV with ViroNovative BV

Diagnostic HYBRIDS and ViroNovative BV have entered into a worldwide licensing agreement covering immunofluorescence-based diagnostic products for human metapneumovirus (hMPV). The non-exclusive agreement allows Diagnostic HYBRIDS to develop, manufacture, market, sell and distribute hMPV-specific antigen detection products upon receiving appropriate regulatory clearance for use in direct specimen detection and with cell culture.

December 12, 2006 Diagnostic HYBRIDS and Immunicon Announce Development and Commercialization Agreement

Privately held Diagnostic HYBRIDS, Inc. (DHI) announced today that it and Immunicon Corporation (NASDAQ-GM:IMMC) of Huntingdon Valley, PA signed a definitive license, development, supply and distribution agreement to develop and commercialize products in the field of clinical virology diagnostics, starting with a panel of multiplex respiratory virus and sexually transmitted infection assays. Financial and other details of the agreement were not disclosed.

September 25, 2006 Diagnostic HYBRIDS Announces Release of Analyte Specific Reagent (ASR) for Metapneumovirus (MPV)

Diagnostic HYBRIDS announced today the release of a new Analyte Specific Reagent (ASR) monoclonal antibody reagent that detects multiple antigens associated with Metapneumovirus (MPV). The reagent is available to clinical laboratories that perform high complexity testing for use in developing their own in-house tests and to non-clinical laboratories e.g. forensic, academic, or research.

July 12, 2006 Diagnostic HYBRIDS Announces Release of New Stain Kit for Identification of Metapneumovirus Antigens

Diagnostic HYBRIDS announced today the release of a new monoclonal antibody stain test system that detects multiple antigens associated with Metapneumovirus (MPV) infections. This kit will be initially available exclusively outside the United States.

May 31, 2006 Diagnostic HYBRIDS Hosts Company Softball Tournament

Each year, Diagnostic HYBRIDS sponsors a softball tournament at the spring CVS show. Here are some pictures from the spring 2006 event.

May 10, 2006 Diagnostic HYBRIDS Presented Innovative Developments at 22nd Clinical Virology Symposium

Diagnostic HYBRIDS presented the latest innovations in cell culture on May 1st at the 22nd Clinical Virology Symposium. Topics ranged from Respiratory and Transport Innovations to Human Metapneumovirus from a Clinical perspective and Monoclonal Antibody Development.

March 10, 2006 New Corporate Identity Positions Diagnostic HYBRIDS’ Brand For Future Growth

Diagnostic HYBRIDS, Inc., a bioscience company that provides cellular and molecular diagnostic kits and biochemical reagents to companies worldwide, unveiled to employees today its new corporate identity package, the theme being "Integrating Science and Humanity."

November 08, 2004 Diagnostic HYBRIDS Ranks No. 219 On Inc. 500 List Of The Fastest Growing U.S. Companies

Diagnostic HYBRIDS Inc., the world’s largest cell culture provider, has ranked No. 219 on Inc. Magazine’s 23rd annual Inc. 500 list of the fastest growing, privately-held companies in the nation. Diagnostic HYBRIDS is the only biomanufacturing company to earn a place on the list and the only company among its fellow honorees from Ohio’s Appalachian Region of the United States.

August 11, 2004 Diagnostic HYBRIDS Receives Investment From Summit Partners

Diagnostic HYBRIDS, the world’s largest cell culture provider, announced today that it has received a $10 million minority investment led by Summit Partners, a leading private equity and venture capital firm with more than $5.5 billion in capital under management. Kenson Ventures, LLC, a venture capital firm focusing on biotechnology and life science investments, also participated in the investment.

July 21, 2004 David Scholl Elected To Chairman Of Omeris' Board Of Trustees

Omeris announced the election of David Scholl, PhD, to chairman of its Board of Trustees. He is president and CEO of Athens, Ohio-based Diagnostics Hybrids